Discover 3,592 paid clinical trials in Santa Ana, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,592
Featured
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer
for
Metastatic Castration-Resistant Prostate Cancer
Location: Los Angeles CA, San Francisco CA, Iowa City IA, Toronto,
Sponsor: Hoffmann-La Roche
Sex: Male
Age: 18+
Code: NCT07287150
Phase 2, Recruiting
Active & Responsive
An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis
for
Plaque Psoriasis
Location: Santa Ana CA, Fountain Valley CA, Los Angeles CA,
Sponsor: Oruka Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07449702
Phase 2, Recruiting
Active & Responsive
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
for
Obesity, Overweight
Location: Santa Ana CA, Fountain Valley CA, Long Beach CA,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07684235
Phase 3, Recruiting
Active & Responsive
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
for
Obesity or Overweight
Location: Santa Ana CA, Chula Vista CA, Rialto CA,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07575399
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
for
Obesity, Overweight
Location: Santa Ana CA, Tustin CA, Fountain Valley CA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07321886
Phase 3, Recruiting
Active & Responsive
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
for
Type 2 Diabetes
Location: Santa Ana CA, Phoenix AZ, Rexburg ID, Redmond WA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT06897475
Phase 2, Recruiting
Active & Responsive
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
Location: Orange CA, Phoenix AZ, San Francisco CA, Dallas TX,
Sponsor: Carl Allen
Sex: All
Age: 0+
Code: NCT04079179
Phase 2, Recruiting
Active & Responsive
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
for
Acute Myeloid Leukemia
Location: Orange CA, Long Beach CA, Las Vegas NV, Phoenix AZ,
Sponsor: PedAL BCU, LLC
Sex: All
Age: 0 - 21
Code: NCT05183035
Phase 3, Recruiting
Active & Responsive
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
for
IGF1 Deficiency
Location: Orange CA, Cincinnati OH, Miami FL
Sponsor: Esteve Pharmaceuticals, S.A.
Sex: All
Age: 2 - 18
Code: NCT00903110
Recruiting
Active & Responsive
A First-in-human Study of S230815 in Pediatric Participants With KCNT1-related Developmental and Epileptic Encephalopathy
for
Epileptic Encephalopathy
Location: Orange CA, Columbus OH, Boston MA
Sponsor: Institut de Recherches Internationales Servier
Sex: All
Age: 2 - 12
Code: NCT07227857
Phase 1, Phase 2, Recruiting
Active & Responsive
A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors
for
Pediatric Tumor of CNS, Pediatric Tumor of Brain,
Location: Orange CA
Sponsor: Neonc Technologies, Inc.
Sex: All
Age: 5 - 18
Code: NCT06357377
Phase 1, Recruiting
Active & Responsive
TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
for
Lymphoblastic Leukemia
Location: Orange CA, Los Angeles CA, Madera CA, Phoenix AZ,
Sponsor: Tanja Andrea Gruber
Sex: All
Age: 0 - 1
Code: NCT05848687
Phase 1, Phase 2, Recruiting
Active & Responsive
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
for
Major Depressive Disorder (MDD),
Location: Orange CA, Chino CA, Glendale CA, West Hills CA,
Sponsor: ACADIA Pharmaceuticals Inc.
Sex: All
Age: 18 - 65
Code: NCT07284667
Phase 2, Recruiting
Active & Responsive
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
for
Sickle Cell Disease
Location: Orange CA, Houston TX, Flowood MS, Chicago IL,